Unknown

Dataset Information

0

Construction of a Competitive Endogenous RNA Network for Pancreatic Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis and a Prognosis Model.


ABSTRACT: Pancreatic adenocarcinoma (PAAD) is a pancreatic disease with considerable mortality worldwide. Because of a lack of obvious symptoms at the early stage, most PAAD patients are diagnosed at the terminal stage and prognosis is usually poor. In this study, we firstly obtained RNA sequencing data of 181 patients with PAAD from The Cancer Genome Atlas (TCGA) database to identify early diagnostic biomarkers for PAAD. Survival-related mRNAs were identified using a weighted gene co-expression network analysis (WGCNA), and then a linear prognostic model of seven long non-coding RNAs (lncRNAs) was established using univariate and multivariate Cox proportional hazards regression analyses, which is verified using a time-dependent receiver operating characteristic (ROC) curve analysis. Finally, according to the survival analysis, we constructed a survival-related competing endogenous RNA (ceRNA) network. Our results showed that: (1) The upregulated genes related to cell cycle-related pathway (including homologous recombination, DNA replication and mismatch repair) in PAAD can increase the proliferation ability of cancer cells; (2) The 7-lncRNA signature can predict the overall survival (OS) of PAAD patients; and (3) The key mRNAs and lncRNAs are involved in mutual regulation in the ceRNA network.

SUBMITTER: Wang J 

PROVIDER: S-EPMC7270201 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Construction of a Competitive Endogenous RNA Network for Pancreatic Adenocarcinoma Based on Weighted Gene Co-expression Network Analysis and a Prognosis Model.

Wang Jing J   Xiang Jinzhu J   Li Xueling X  

Frontiers in bioengineering and biotechnology 20200528


Pancreatic adenocarcinoma (PAAD) is a pancreatic disease with considerable mortality worldwide. Because of a lack of obvious symptoms at the early stage, most PAAD patients are diagnosed at the terminal stage and prognosis is usually poor. In this study, we firstly obtained RNA sequencing data of 181 patients with PAAD from The Cancer Genome Atlas (TCGA) database to identify early diagnostic biomarkers for PAAD. Survival-related mRNAs were identified using a weighted gene co-expression network a  ...[more]

Similar Datasets

| S-EPMC10806165 | biostudies-literature
| S-EPMC9130708 | biostudies-literature
| S-EPMC7288603 | biostudies-literature
| S-EPMC9018166 | biostudies-literature
| S-EPMC6814619 | biostudies-other
| S-EPMC6485208 | biostudies-literature
| S-EPMC9429583 | biostudies-literature
| S-EPMC8818217 | biostudies-literature
| S-EPMC7895565 | biostudies-literature
| S-EPMC6787165 | biostudies-literature